Global Paclitaxel Market Survey and Trend Research 2018

December 2017 | 87 pages | ID: G372A350648EN
99Strategy

Abstracts

SUMMARY

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Phyton, ScinoPharm, Novasep, Samyang, TAPI(Teva), TAPI(Teva), Fresenius-kabi, Southpharma, Haiyao, Huiang biopharma, Yunnan Hande, Hainan Yew Pharm etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Paclitaxel Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 PACLITAXEL MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Phyton (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 ScinoPharm (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Novasep (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Samyang (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 TAPI(Teva) (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 TAPI(Teva) (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Fresenius-kabi (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Southpharma (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Haiyao (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Huiang biopharma (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Yunnan Hande (Company Overview, Sales Data etc.)
4.12 Hainan Yew Pharm (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Paclitaxel Market 2012-2017, by Type, in USD Million
Table Global Paclitaxel Market 2012-2017, by Type, in Volume
Table Global Paclitaxel Market Forecast 2018-2023, by Type, in USD Million
Table Global Paclitaxel Market Forecast 2018-2023, by Type, in Volume
Table Phyton Overview List
Table Paclitaxel Business Operation of Phyton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ScinoPharm Overview List
Table Paclitaxel Business Operation of ScinoPharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novasep Overview List
Table Paclitaxel Business Operation of Novasep (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Samyang Overview List
Table Paclitaxel Business Operation of Samyang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TAPI(Teva) Overview List
Table Paclitaxel Business Operation of TAPI(Teva) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TAPI(Teva) Overview List
Table Paclitaxel Business Operation of TAPI(Teva) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fresenius-kabi Overview List
Table Paclitaxel Business Operation of Fresenius-kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Southpharma Overview List
Table Paclitaxel Business Operation of Southpharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Haiyao Overview List
Table Paclitaxel Business Operation of Haiyao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Huiang biopharma Overview List
Table Paclitaxel Business Operation of Huiang biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Yunnan Hande Overview List
Table Paclitaxel Business Operation of Yunnan Hande (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hainan Yew Pharm Overview List
Table Paclitaxel Business Operation of Hainan Yew Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Paclitaxel Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Paclitaxel Sales Revenue Share, by Companies, in USD Million
Table Global Paclitaxel Sales Volume 2012-2017, by Companies, in Volume
Table Global Paclitaxel Sales Revenue Share, by Companies in 2017, in Volume
Table Paclitaxel Demand 2012-2017, by Application, in USD Million
Table Paclitaxel Demand 2012-2017, by Application, in Volume
Table Paclitaxel Demand Forecast 2018-2023, by Application, in USD Million
Table Paclitaxel Demand Forecast 2018-2023, by Application, in Volume
Table Global Paclitaxel Market 2012-2017, by Region, in USD Million
Table Global Paclitaxel Market 2012-2017, by Region, in Volume
Table Paclitaxel Market Forecast 2018-2023, by Region, in USD Million
Table Paclitaxel Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Paclitaxel Industry Chain Structure
Figure Global Paclitaxel Market Growth 2012-2017, by Type, in USD Million
Figure Global Paclitaxel Market Growth 2012-2017, by Type, in Volume
Figure Global Paclitaxel Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Paclitaxel Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region